Ampoules
Sealed glass ampoules for single-dose liquid injections.
Sterile manufacturing, where sterile expertise meets manufacturing scale
From ampoules and vials to dry powder injections, large volume parenterals, pre-filled syringes and sterile drops, Akums brings together capabilities across five sterile manufacturing units, with additional capacity in development.
Sterile dosage forms. Diverse delivery options.
Liquid and powder injections, infusions, pre-filled syringes, inhalation respules, and sterile ophthalmic, otic and nasal drops.
Liquid vials
Stoppered glass vials for ready-to-inject solutions.
Multi-dose vials
Larger vials designed for several doses from one container.
Three-piece packs
A vial, a diluent and a closure system packed together for reconstitution.
Large volume parenterals
Infusion packs for fluids and drugs given over a longer period.
Pre-filled syringes
Ready-to-use syringes that save preparation time and reduce dosing errors.
Dry powder injections
Powder-filled vials reconstituted before use, including segregated beta-lactam lines.
Lyophilised vials
Freeze-dried products for actives that are unstable in solution.
Form-fill-seal packs
Plastic unit-dose containers formed, filled and sealed in one sterile step.
Respules
Single-dose sterile ampoules of solution for nebulised inhalation.
Eye, ear and nasal drops
Sterile drops made in a dedicated unit for ophthalmic and nasal use.
Small volume parenterals
Low-volume injectable solutions in ampoules and vials for routine hospital use.
Across sterile formats and manufacturing processes
Liquid and powder injectables
Manufacturing of liquid and dry-powder injectable formulations in suitable sterile presentations, including vials and ampoules.
Dedicated beta-lactam facilities
Segregated manufacturing facilities for penicillin- and cephalosporin-based dry-powder injections, in line with applicable product and facility requirements.
Specialised sterile formats
Selected form-fill-seal (FFS) products, pre-filled syringes and inhalation respules, subject to the capabilities of the relevant facility.
Large-volume parenterals
Manufacturing of large-volume parenteral solutions for infusion, alongside small-volume injectable formulations.
Advancing lyophilised injectable manufacturing
New lyophilisation facility
Dedicated lyophilised injectable capabilities
Specialised manufacturing for freeze-dried injectable formulations in vials, designed to support products where stability, formulation integrity and shelf-life requirements make lyophilisation essential.
Precision in freeze-drying
Controlled lyophilisation processes tailored to product-specific formulation and quality requirements.
Support for complex formulations
Capabilities designed for injectable products that require specialised processing to meet their quality and stability requirements.
Five sterile units, with one more coming
Pick a format to see which units make it and what approvals each one holds. That way you can plan a primary site and a backup that suits your market.
5 sterile units across 3 locations, plus 1 unit coming soon.
Haridwar, Uttarakhand
Sterile Preparations Unit
Ampoules, vials, three-piece packs, small and large volume parenterals and pre-filled syringes, plus segregated dry powder injection lines for penicillins and cephalosporins and a dedicated eye and nasal drops line.
ANVISAISO 9001ISO 14001ISO 45001ISO 50001
Regulatory approvals (12)
- Brazilian Health Regulatory Agency (ANVISA)
- Bulgarian Drug Agency
- Food Safety and Drug Administration, Uttarakhand
- Ministry of Health, Cambodia
- Ethiopian Food and Drug Authority
- Pharmacy, Medicines and Poisons Board, Malawi
- Ministry of Health and Population, Nepal
- NAFDAC, Nigeria
- Pharmacy and Poisons Board, Kenya
- Food and Drug Administration, Philippines
- National Medicines and Poisons Board, Sudan
- National Drug Authority, Uganda
Haridwar, Uttarakhand
Hormonal Unit
Hormonal injectables in vials and ampoules.
ISO 9001ISO 14001ISO 45001ISO 50001
Regulatory approvals (10)
- Food Safety and Drug Administration, Uttarakhand
- Ministry of Health, Cambodia
- Ethiopian Food and Drug Authority
- National Agency of Drug and Food Control, Indonesia
- Pharmacy, Medicines and Poisons Board, Malawi
- Ministry of Health and Population, Nepal
- NAFDAC, Nigeria
- Food and Drug Administration, Philippines
- Ministry of Health, Vietnam
- Pharmacy and Medicines Regulatory Authority, Zambia
Haridwar, Uttarakhand
Multi-Dosage Unit
Ampoules, three-piece vials, dry powder injections, form-fill-seal packs and large volume parenterals across two injectable units.
ISO 9001ISO 14001ISO 22000ISO 45001ISO 50001
Regulatory approvals (2)
- Food Safety and Drug Administration, Uttarakhand
- Ministry of Public Health and Population, Yemen
Roorkee, Uttarakhand
Anti-Bacterials and Steroids Unit
Cephalosporin dry powder injections in a segregated unit.
ISO 9001ISO 14001ISO 45001ISO 50001
Regulatory approvals (7)
- Food Safety and Drug Administration, Uttarakhand
- Ministry of Health, Cambodia
- Pharmacy and Poisons Board, Kenya
- Pharmacy, Medicines and Poisons Board, Malawi
- NAFDAC, Nigeria
- Tanzania Medicines and Medical Devices Authority
- National Drug Authority, Uganda
Kotdwar, Uttarakhand
Beta-Lactam Unit
Beta-lactam dry powder injections.
WHO-GMP
Regulatory approvals (3)
- National Drug Authority, Uganda
- Ministry of Health, Cambodia
- Pharmacy and Medicines Regulatory Authority, Malawi
Haridwar, UttarakhandComing soon
Multi-Format Sterile Unit
Ampoules, vials, lyophilised vials, form-fill-seal packs, respules and water for injection.
WHO-GMP
A manufacturing network built for supply continuity
Akums' multi-location sterile manufacturing network offers pharmaceutical partners access to diverse capabilities across Uttarakhand. Site selection and product allocation are guided by manufacturing suitability, capacity and applicable regulatory approvals.
Three sterile manufacturing locations
Manufacturing facilities across Haridwar, Roorkee and Kotdwar, Uttarakhand.
Dry-powder injection capabilities across four units
Including three units with dedicated beta-lactam manufacturing lines.
Site-specific regulatory approvals
Facility approvals and target-market requirements can be evaluated early to support manufacturing decisions and second-source planning.
Expanding sterile capabilities
A new multi-format sterile unit in Haridwar is planned to expand capabilities in lyophilised vials, inhalation respules and water for injection.
Sterile products across therapeutic areas
Antibiotics
Pain management
Analgesics
Gastrointestinal
Antiemetics
Corticosteroids
Hormones
Gynaecology
Respiratory
Antiasthmatic
Haematinics
Antipyretics
Cardiovascular
Central nervous systemAnd many more, backed by regulatory approvals across more than 60 countries.